Advertisement
Advertisement
NRXP
NRX Pharmaceuticals, Inc. Common Stock
3.56
USDSponsored
-0.20
-5.32%
Jun 24, 16:00 UTC -4
Closed
Pre-Market
3.58
+0.02
+0.56%
NRXP Earnings Reports
Positive Surprise Ratio
NRXP beat 7 of 16 last estimates.
44%
Next Report
Date of Next Report
Aug 17, 2026
Estimate for Q2 26 (Revenue/ EPS)
$16.89M
/$0.06
Implied change from Q1 26 (Revenue/ EPS)
+1481.81%
/-250.00%
Implied change from Q2 25 (Revenue/ EPS)
--
/-119.35%
NRX Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On May 15, 2026, NRXP reported earnings of -0.04 USD per share (EPS) for Q1 26, missing the estimate of 0.29 USD, resulting in a -113.64% surprise. Revenue reached 1.07 million, compared to an expected 26.08 million, with a -95.90% difference. The market reacted with a -5.03% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of 0.06 USD, with revenue projected to reach 16.89 million USD, implying an decrease of -250.00% EPS, and increase of 1481.81% in Revenue from the last quarter.
FAQ
What were NRX Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, NRX Pharmaceuticals, Inc. Common Stock reported EPS of -$0.04, missing estimates by -113.64%, and revenue of $1.07M, -95.9% below expectations.
How did the market react to NRX Pharmaceuticals, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -5.03%, changed from $3.28 before the earnings release to $3.12 the day after.
When is NRX Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 17, 2026.
What are the forecasts for NRX Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on --
analysts, NRX Pharmaceuticals, Inc. Common Stock is expected to report EPS of $0.06 and revenue of $16.89M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement